RxDoctor Payments Data

Samantha Margulies, MD

Urogynecology and Reconstructive Pelvic Surgery · West Palm Beach, FLNPI 1922454842

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 34.3% of the total. Reporting peaked in 2024 at $5,058 and has fallen 70.9% since, to $1,473 in 2025.

$10,984in general payments, 2019–2025

Across 117 payments — averaging $93.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Coloplast$3K
  • Boston Scientific$1K
  • Intuitive Surgical$1K
  • Bluewind Medical$673
  • Caldera Medical, Inc$340
  • plus $1K from 6 others

What the payments were for

  • Travel & lodging$5,81453%
  • Food & beverage$4,17038%
  • Education$1,0009%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,984 in reported general payments places this provider in the 75th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.

See all urogynecology and reconstructive pelvic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$273,410
Medicare patients
550
Services billed
5,500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol527$30,422
MyrbetriqMirabegron39$20,885
GemtesaVibegron27$15,326
Methenamine Hippurate22$1,379
Clobetasol Propionate23$483
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst48$477
Amitriptyline Hcl25$182
Fluconazole19$83
Oxycodone Hcl43$77
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$56

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in West Palm Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →